- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Ulf H. Grundmann
News 25 results
Recognition
May 17, 2024
LMG Life Sciences EMEA Names Ulf Grundmann its Parallel Import Lawyer of the Year
Recognition
March 27, 2024
Legal 500 EMEA 2024 Ranks King & Spalding among the Top Firms in Europe, the Middle East and Africa
Recognition
February 19, 2024
Legal 500 Deutschland 2024 Ranks King & Spalding Among Germany’s Leading Law Firms
Recognition
November 15, 2023
King & Spalding Once Again Receives Novartis’ “Excellence in Litigation” Award
Recognition
November 10, 2023
JUVE Handbook 2023/24 Recognizes Multiple King & Spalding Practices, Individuals
Recognition
Recognition
June 28, 2023
Best Lawyers Recognizes International King & Spalding Lawyers in its 2024 Guides
Recognition
June 22, 2023
King & Spalding Wins Impact Case of the Year Award
Recognition
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
Recognition
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
In the News · Source: JUVE, Managing IP and Global Legal Chronicle
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
Cases & Deals
November 17, 2022
King & Spalding represents Novartis on landmark ECJ pharma packaging victory